Your session is about to expire
← Back to Search
Toric Intraocular Lens
Lower Cylinder Toric IOL for Cataract (ANCORA Trial)
N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Surgical Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-month
Awards & highlights
ANCORA Trial Summary
This study is evaluating whether a new treatment for knee osteoarthritis may help reduce pain and improve function.
Eligible Conditions
- Corneal Astigmatism
- Cataract
ANCORA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of Bothersome Visual Symptoms
Rate of Difficulty With an Activity Due to the Visual Symptoms
ANCORA Trial Design
2Treatment groups
Active Control
Group I: Lower Cylinder Toric IOLActive Control1 Intervention
Consented subjects that are eligible will have both eyes implanted with a TECNIS Symfony IOL. Each eye may have a different TECNIS Symfony IOL implanted, as determined by the surgeon and the TECNIS Symfony Toric IOL calculator; however, at least one eye must be implanted with either a Symfony Toric IOL Model ZXT150 (lower-cylinder group) or a Model ZXT300 or ZXT375 (higher-cylinder group) and the fellow eye must have the same or a lower toric power. The eye with the highest toric power IOL will determine the model group.
Group II: Higher Cylinder Toric IOLActive Control1 Intervention
Consented subjects that are eligible will have both eyes implanted with a TECNIS Symfony IOL. Each eye may have a different TECNIS Symfony IOL implanted, as determined by the surgeon and the TECNIS Symfony Toric IOL calculator; however, at least one eye must be implanted with either a Symfony Toric IOL Model ZXT150 (lower-cylinder group) or a Model ZXT300 or ZXT375 (higher-cylinder group) and the fellow eye must have the same or a lower toric power. The eye with the highest toric power IOL will determine the model group.
Find a Location
Who is running the clinical trial?
Johnson & Johnson Surgical Vision, Inc.Lead Sponsor
34 Previous Clinical Trials
7,583 Total Patients Enrolled
29 Trials studying Cataract
6,354 Patients Enrolled for Cataract
Johnson & Johnson Surgical Vision Clinical TrialsStudy DirectorJohnson & Johnson Surgical Vision
17 Previous Clinical Trials
2,546 Total Patients Enrolled
12 Trials studying Cataract
1,468 Patients Enrolled for Cataract
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger